Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07464236 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Clinic Delivery of HIV-related Anal Health Services

Study acronym: PEACHES 2
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 1, 2026 to Feb 2028 Show 4 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Collaborators: 3 to 4
    • Publications: details revised at 18 of 20 entries
  2. Start date: May 1, 2026 to Aug 1, 2026
    • Primary and study completion pushed from Apr 30, 2030 to Jul 31, 2030
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project will test ways to reduce stigma in healthcare settings so that more providers offer, and more patients receive, important anal sex-related HIV services, including anorectal sexually transmitted infection (STI) testing, preventive medications, and cancer screening. By evaluating these stigma-reduction strategies in eight clinics in the Mississippi Delta, a region with high rates of HIV and STIs, the research team will learn whether and how these approaches work to improve access to care. The results will help guide healthcare systems in using the most effective methods to reduce stigma, making it easier for people to get prevention services and improving public health.
Trial Details
NCT Number NCT07464236
Lead Sponsor Albert Einstein College of Medicine
Collaborators: Columbia University, Denver Prevention Training Center, Coastal Family Health Center, National Cancer Institute (NCI)
Conditions
(from sponsor)		 HIV, Gonorrhea, Chlamydia, Anal Cancer Squamous Cell
Related terms Anus Neoplasms, Chlamydia Infections, Gonorrhea
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov